Cloning of deleted sequences (CODE)

A genomic subtraction method for enriching and cloning deleted sequences

J. Li, F. Wang, V. Kashuba, Claes R Wahlestedt, E. R. Zabarovsky

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The deletion of specific genomic sequences is believed to influence the pathogenesis of certain diseases such as cancer. Identification of these sequences could provide novel therapeutic avenues for the treatment of disease. Here, we describe a simple and robust method called cloning of deleted sequences (CODE), which allows the selective cloning of deleted sequences from complex human genomes. Briefly, genomic DNA from two sources (human normal and tumor samples) was digested with restriction enzymes (e.g., BamHI, BglII, and BclI), then ligated to special linkers, and amplified by PCR. Tester (normal) DNA was amplified using a biotinylated primer and dNTPs. Driver (tumor) DNA was amplified using a non-biotinylated primer, but with dUTP instead of dTTP. After denaturation and hybridization, all the driver DNA was destroyed with uracil-DNA glycosylase (UDG), and all imperfect hybrids were digested with mung bean nuclease. Sequences deleted from the driver DNA but present in the tester DNA were purified with streptavidin magnetic beads, and the cycle was repeated three more times. This procedure resulted in the rapid isolation and efficient cloning of genomic sequences homozygously deleted from the driver DNA sample, but present in the tester DNA fraction.

Original languageEnglish
Pages (from-to)788-793
Number of pages6
JournalBioTechniques
Volume31
Issue number4
StatePublished - Oct 24 2001
Externally publishedYes

Fingerprint

Cloning
Organism Cloning
DNA
Tumors
Uracil-DNA Glycosidase
Neoplasms
Denaturation
Streptavidin
Human Genome
Genes
Polymerase Chain Reaction
Enzymes
Therapeutics

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Cloning of deleted sequences (CODE) : A genomic subtraction method for enriching and cloning deleted sequences. / Li, J.; Wang, F.; Kashuba, V.; Wahlestedt, Claes R; Zabarovsky, E. R.

In: BioTechniques, Vol. 31, No. 4, 24.10.2001, p. 788-793.

Research output: Contribution to journalArticle

Li, J. ; Wang, F. ; Kashuba, V. ; Wahlestedt, Claes R ; Zabarovsky, E. R. / Cloning of deleted sequences (CODE) : A genomic subtraction method for enriching and cloning deleted sequences. In: BioTechniques. 2001 ; Vol. 31, No. 4. pp. 788-793.
@article{0ad118d17408490ca254368718b9587b,
title = "Cloning of deleted sequences (CODE): A genomic subtraction method for enriching and cloning deleted sequences",
abstract = "The deletion of specific genomic sequences is believed to influence the pathogenesis of certain diseases such as cancer. Identification of these sequences could provide novel therapeutic avenues for the treatment of disease. Here, we describe a simple and robust method called cloning of deleted sequences (CODE), which allows the selective cloning of deleted sequences from complex human genomes. Briefly, genomic DNA from two sources (human normal and tumor samples) was digested with restriction enzymes (e.g., BamHI, BglII, and BclI), then ligated to special linkers, and amplified by PCR. Tester (normal) DNA was amplified using a biotinylated primer and dNTPs. Driver (tumor) DNA was amplified using a non-biotinylated primer, but with dUTP instead of dTTP. After denaturation and hybridization, all the driver DNA was destroyed with uracil-DNA glycosylase (UDG), and all imperfect hybrids were digested with mung bean nuclease. Sequences deleted from the driver DNA but present in the tester DNA were purified with streptavidin magnetic beads, and the cycle was repeated three more times. This procedure resulted in the rapid isolation and efficient cloning of genomic sequences homozygously deleted from the driver DNA sample, but present in the tester DNA fraction.",
author = "J. Li and F. Wang and V. Kashuba and Wahlestedt, {Claes R} and Zabarovsky, {E. R.}",
year = "2001",
month = "10",
day = "24",
language = "English",
volume = "31",
pages = "788--793",
journal = "BioTechniques",
issn = "0736-6205",
publisher = "Eaton Publishing Company",
number = "4",

}

TY - JOUR

T1 - Cloning of deleted sequences (CODE)

T2 - A genomic subtraction method for enriching and cloning deleted sequences

AU - Li, J.

AU - Wang, F.

AU - Kashuba, V.

AU - Wahlestedt, Claes R

AU - Zabarovsky, E. R.

PY - 2001/10/24

Y1 - 2001/10/24

N2 - The deletion of specific genomic sequences is believed to influence the pathogenesis of certain diseases such as cancer. Identification of these sequences could provide novel therapeutic avenues for the treatment of disease. Here, we describe a simple and robust method called cloning of deleted sequences (CODE), which allows the selective cloning of deleted sequences from complex human genomes. Briefly, genomic DNA from two sources (human normal and tumor samples) was digested with restriction enzymes (e.g., BamHI, BglII, and BclI), then ligated to special linkers, and amplified by PCR. Tester (normal) DNA was amplified using a biotinylated primer and dNTPs. Driver (tumor) DNA was amplified using a non-biotinylated primer, but with dUTP instead of dTTP. After denaturation and hybridization, all the driver DNA was destroyed with uracil-DNA glycosylase (UDG), and all imperfect hybrids were digested with mung bean nuclease. Sequences deleted from the driver DNA but present in the tester DNA were purified with streptavidin magnetic beads, and the cycle was repeated three more times. This procedure resulted in the rapid isolation and efficient cloning of genomic sequences homozygously deleted from the driver DNA sample, but present in the tester DNA fraction.

AB - The deletion of specific genomic sequences is believed to influence the pathogenesis of certain diseases such as cancer. Identification of these sequences could provide novel therapeutic avenues for the treatment of disease. Here, we describe a simple and robust method called cloning of deleted sequences (CODE), which allows the selective cloning of deleted sequences from complex human genomes. Briefly, genomic DNA from two sources (human normal and tumor samples) was digested with restriction enzymes (e.g., BamHI, BglII, and BclI), then ligated to special linkers, and amplified by PCR. Tester (normal) DNA was amplified using a biotinylated primer and dNTPs. Driver (tumor) DNA was amplified using a non-biotinylated primer, but with dUTP instead of dTTP. After denaturation and hybridization, all the driver DNA was destroyed with uracil-DNA glycosylase (UDG), and all imperfect hybrids were digested with mung bean nuclease. Sequences deleted from the driver DNA but present in the tester DNA were purified with streptavidin magnetic beads, and the cycle was repeated three more times. This procedure resulted in the rapid isolation and efficient cloning of genomic sequences homozygously deleted from the driver DNA sample, but present in the tester DNA fraction.

UR - http://www.scopus.com/inward/record.url?scp=0034797258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034797258&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 788

EP - 793

JO - BioTechniques

JF - BioTechniques

SN - 0736-6205

IS - 4

ER -